期刊文献+

白藜芦醇抑制荷骨肉瘤小鼠肿瘤生长的机制研究 被引量:3

Resveratrol inhibits growth of osteosarcoma transplanted in mice
下载PDF
导出
摘要 目的:探讨白藜芦醇(RES)抗荷骨肉瘤小鼠移植瘤生长的作用及其机制。方法:构建小鼠移植瘤模型,RES注射给药,每日观察体重及瘤体变化,RT-qPCR检测肿瘤细胞Xiap、Kras、Mcl-1、Bcl-2、CyclinE1、BAX基因的表达,Western blot检测相应蛋白表达;流式细胞术检测体内外肿瘤细胞PD-L1表达,以及移植瘤组织中CD8+T细胞、NK细胞、NKT细胞、MDSCs和Treg细胞数量。结果:RES能抑制小鼠移植瘤生长;在体外增强而在体内降低了肿瘤细胞表面PD-L1表达;下调肿瘤细胞Xiap、Kras、Mcl-1、Bcl-2、CyclinE1 mRNA及相应蛋白的表达,提高BAX mRNA及相应蛋白表达水平;增加肿瘤组织中CD8+T细胞、NK细胞、NKT细胞百分比,降低MDSCs和Treg细胞百分比。结论:RES能显著抑制荷骨肉瘤小鼠移植瘤生长,其机制与调控细胞凋亡和细胞周期相关基因和蛋白表达有关;同时,RES能调节移植瘤中多种免疫细胞发挥抗肿瘤效应。 Objective:To investigate the mechanism involved in the effect of resveratrol(RES) on inhibiting the growth of osteosarcoma.Methods:Osteosarcoma transplanted mice model was constructed and treated with RES at different doses, the body weight and tumor volume of the mice were recorded daily.The gene expression of Xiap, Kras, Mcl-1,Bcl-2,CyclinE1 and BAX in tumor cells were detected by RT-qPCR and the expression of the corresponding proteins were checked by Western blot.The expression of PD-L1 on tumor cells in vitro and in vivo and the percentages of CD8+T cells, NK cells, NKT cells, MDSCs and Treg cells infiltrating in transplanted tumor tissues were measured by flow cytometry.Results:RES inhibited the growth of osteosarcoma transplanted in mice.RES enhanced the expression of PD-L1 in vitro and down-regulated it in vivo.RES treatment decreased the mRNAs and corresponding proteins expression levels of XIAP,Kras, Mcl-1,Bcl-2,CyclinE1.On the other hand, RES treatment enhanced that expression of BAX in tumor cells.RES treatment increased the percentages of CD8+T cells, NK cells, NKT cells and decreased the percentages of MDSCs and Treg cells in tumor tissues.Conclusion:RES has the potential to inhibited the growth of osteosarcoma transplanted in K7 M2 mice.The mechanism is related to regulating the apoptosis and cell cycle-related genes and proteins expression.At the same time, RES regulates various immune cells to exert anti-tumor effects.
作者 童晨曦 杨雪婷 周恩俊 曾艳 陈昌蓉 宋银宏(指导) TONG Chen-Xi;YANG Xue-Ting;ZHOU En-Jun;ZENG Yan;CHEN Chang-Rong;SONG Yin-Hong(Medical College,China Three Gorges University,Institute of Infection and Inflammation,China Three Gorges University,Yichang 443002,China)
机构地区 三峡大学医学院
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2021年第5期557-563,共7页 Chinese Journal of Immunology
基金 国家自然科学基金(81671397) 湖北省宜昌市科技局项目(A16-301-32)资助。
关键词 白藜芦醇 骨肉瘤 细胞凋亡 细胞周期 肿瘤微环境 Resveratrol Osteosarcoma Cell apoptosis Cell cycle Tumor microenvironment
  • 相关文献

参考文献2

二级参考文献12

  • 1Wolchok JD,Kluger H,Callahan MK,Postow MA,Rizvi NA,Lesokhin AM,Segal NH,Ariyan CE,Gordon RA,Reed K,Burke MM,Caldwell A,Kronenberg SA,Agunwamba BU,Zhang X,Lowy I,Inzunza HD,Feely W,Horak CE,Hong Q,Korman AJ,Wigginton JM,Gupta A,Sznol M.Nivolumab plus ipilimumab in advanced melanoma. The New England Journal of Medicine . 2013
  • 2Ilkovitch Dan,Lopez Diana M.The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Research . 2009
  • 3Fumitaka Arihara,Eishiro Mizukoshi,Masaaki Kitahara,Yoshiko Takata,Kuniaki Arai,Tatsuya Yamashita,Yasunari Nakamoto,Shuichi Kaneko.Increase in CD14 + HLA-DR ?/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis[J]. Cancer Immunology, Immunotherapy . 2013 (8)
  • 4MasatoSakon,HiroakiNagano,KeizoDono,ShojiNakamori,KojiUmeshita,AkiraYamada,SumioKawata,YasuharuImai,ShoheiIijima,MoritoMonden.Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches[J]. Cancer . 2002 (2)
  • 5Chen, L,D. B. Flies."Molecular mechanisms of T cell co-stimulation and co-inhibition.". Nature Reviews Immunology . 2013
  • 6The International Consensus Group for Hepatocellular Neoplasia.Pathologic diagnosis of early hepatocellular carcinoma:a report of the international consensus group for hepatocellular neoplasia. Hepatology . 2009
  • 7Ayaru L,Pereira SP,Alisa A, et al.Unmasking of alpha-fetoprotein-specific CD4 (+) T cell responses in hepatocellular carcinoma patients undergoing embolization. J Immunol . 2007
  • 8Gao H,Li K,Tu H,et al.Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma. Clinical Cancer Research . 2014
  • 9H. Chi,S. J. Liu,C. P. Li,H. P. Kuo,Y. S. Wang,Y.Chao,S. L. Hsieh.Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma. Journal of Immunotherapy . 2005
  • 10D.H. Palmer,R.S. Midgley,N. Mirza,E.E. Torr,F. Ahmed,J.C. Steele,N.M. Steven,D.J. Kerr,L.S. Young,D.H. Adams.A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology . 2009

共引文献21

同被引文献26

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部